Achievement and Maintenance Of Deeper Molecular Response By Switching To Nilotinib In Patients (pts) With Chronic Myeloid Leukemia In Chronic Phase (CML-CP) With Residual Disease On Long-Term Imatinib: ENESTcmr 36-Month Follow-Up
| Autor: | Leber, Brian, Cervantes, Francisco, Spector, Nelson, Lipton, Jeffrey H., Etienne, Gabriel *, Pasquini, Ricardo, Clementino, Nelma Christina *, Guerci-Bresler, Agnès *, Forrest, Donna, Schwarer, Anthony P., Acharya, Sandip *, Collins, LaTonya *, Szczudlo, Tomasz, Hughes, Timothy P. |
|---|---|
| Zdroj: | In Blood 15 November 2013 122(21):94-95 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|